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Abstract
Background—Despite the increasing use of nasoalveolar molding (NAM) in early cleft 
treatment, questions remain about its effectiveness. This study examines clinician and caregiver 
appraisals of primary cleft lip and nasal reconstruction with and without NAM in a non-
randomized, prospective multicenter study.
Methods—Participants were 110 infants with cleft lip/palate (62 treated with NAM and 48 
treated without NAM (NO-NAM)) and their caregivers seeking treatment at one of six high-
volume cleft centers. Using the Extent of Difference Scale, standard photos for a randomized 
subset of 54 infants were rated pre-treatment and post-surgery by an expert clinician blinded to 
treatment group. Standard blocked and cropped photos included frontal, basal, left and right views 
of the infants. Using the same scale, caregivers rated their infants’ lip, nose, and facial appearance 
compared to the general population of infants without clefts pre-treatment and post-surgery. 
Multilevel modeling was used to model change in ratings of infants’ appearance pre-treatment and 
post-surgery.
Results—The expert clinician ratings indicated that NAM-treated infants had more severe clefts 
at pre-treatment; yet both groups were rated equally post-surgery. NAM caregivers reported better 
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post-surgery outcomes compared to NO-NAM caregivers (p<0.05), particularly in relation to the 
appearance of the nose.
Conclusions—Despite having a more severe cleft before treatment, infants who underwent 
NAM were found by clinician ratings to have comparable results to those who underwent lip 
repair alone. Infants who underwent NAM were perceived by caregivers to have better treatment 
outcomes than those that underwent lip repair without NAM.
INTRODUCTION
The development of nasoalveolar molding (NAM) was inspired by the need for more 
reproducible and better aesthetic results following primary cleft lip and nasal reconstruction 
despite cleft severity [1, 2]. Through weekly or biweekly modifications of an alveolar 
molding plate and nasal stent, NAM is designed to align the alveolar segments, lengthen the 
columella, increase nasal tip projection, shape the lower lateral cartilages, medially 
transpose the alar base, and stretch the intranasal lining [3, 4].
A growing number of cleft centers now offer NAM [5] and research has reported on the 
benefits of NAM or a similar variation of presurgical orthopedics [6, 7]. For example, 
patients with unilateral cleft lip who undergo NAM reportedly demonstrate greater nasal 
symmetry through 9 years of age than patients with unilateral cleft lip who do not have 
NAM [8]. Additionally, compared to children without cleft, patients with bilateral clefts 
treated with NAM have near normal nasal morphology through 12.5 years of age [9]. 
Despite the increasing volume of NAM research, use of NAM remains an area of active 
debate [3, 10]. The transition from small, retrospective, single-center reports, to larger, 
prospective, multi-center studies is necessary to provide more robust scientific outcomes 
regarding treatment effectiveness. To date, virtually all reports on the effects of NAM on 
facial appearance have been of the former design.
The evaluation of facial appearance is an important outcome variable in the study of health-
related quality of life and the impact of cleft treatment [11–13]. Given the importance of 
facial attractiveness, much research has been devoted to understanding subjective 
evaluations or ratings of facial difference. However, the selection and composition of raters 
may have a significant impact on study findings [11]. For example, even though laypersons 
and professionals can reliably differentiate between varying levels of facial attractiveness 
[14], professionals reportedly rate facial difference more severely than laypersons [15, 16]. 
This rating discrepancy may be attributed to medical training that teaches professionals to be 
more aware and critical of minute differences in facial appearance. The relevance of patient-
reported outcomes is now recognized as a crucial endpoint in treatment success [17], yet 
relatively little is known about how caregiver evaluations of appearance compare to 
evaluations by healthcare professionals. This non-randomized, prospective, multicenter 
study investigates the subjective assessment of the surgical outcomes of primary cleft lip and 
nasal repair with and without NAM by both caregivers and an experienced clinician, blinded 
to treatment group, time and site. The research questions are: 1) What is the expert 
clinician’s assessment of facial appearance before and after cleft lip and nasal repair in 
infants undergoing NAM compared to infants undergoing traditional care without NAM 
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(NO-NAM), and 2) What are the caregivers’ assessment of their infants’ facial appearance 
before and after cleft lip and nasal repair in infants undergoing NAM compared to NO-
NAM?
PATIENTS AND METHODS
Sample/Procedures
This non-randomized, prospective multicenter study includes patients undergoing cleft lip 
reconstruction at six cleft/craniofacial centers: University of North Carolina-Chapel Hill, 
Oregon Health and Science University, New York University Langone Medical Center, 
Children's Healthcare of Atlanta, Mercy Children’s Hospital (St. Louis, MO), and Riley 
Hospital for Children (Indianapolis, IN). All study sites are approved by the Commission on 
Approval of Teams (CAT) of the American Cleft Palate Craniofacial Association (ACPA) 
and Cleft Palate Foundation (CPF) and are high volume, nationally recognized, and 
geographically diverse cleft centers. The caregivers of infants with non-syndromic complete 
unilateral or bilateral cleft lip with or without a cleft palate and no other major medical 
issues were recruited for the study. Caregivers with a major psychiatric disorder (e.g., 
schizophrenia) that might interfere with their ability to adhere to the study protocol or who 
could not speak or understand English or Spanish were excluded. Spanish interpreters were 
available on-site, as needed.
In all instances, reconstructive surgeons at the study sites delivered the study’s outlined 
standardized treatment presentation to eligible caregivers, regardless of cleft severity. This 
presentation included viewing pre- and post-surgery photographs, explaining treatment 
protocol(s), and answering questions. Once the caregivers made a treatment decision for 
their infants as either NAM (early intervention with NAM followed by cleft lip surgery) or 
NO-NAM (cleft lip surgery only), patient care coordinators were then responsible for 
recruiting and obtaining the caregivers’ written informed consent. The caregivers’ treatment 
decision alone determined group assignment. Caregivers consented to complete 
questionnaires and to have photographs taken of their infant for viewing by a clinician rater. 
The project was approved by the Institutional Review Board at each institution.
One hundred and ten patients were recruited to this study: 62 infants had NAM and 48 
underwent surgical repair alone (NO-NAM). Forty-nine (79%) of the children treated with 
NAM and 35 (73%) of the children treated without NAM had unilateral clefts. NAM 
caregivers completed the Extent of Difference (EOD) questionnaire prior to NAM treatment 
(infant ~6 weeks old), at the end of NAM treatment and prior to lip surgery, and following 
secondary palate surgery (infant ~13 months old). NO-NAM caregivers completed the EOD 
questionnaire prior to lip surgery and following secondary palate surgery (~13 months old).
Measure
Extent of Difference (EOD) Scale—The EOD includes a four-point rating of the 
appearance of the infant’s overall face, nose, and lips as compared to children without cleft 
in the general population: 0 - same as other children (not different); 1 - a little different 
(mildly different), 2 - more than a little different (moderately different), and 3 - very 
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different. The EOD is an adaptation of the severity scale developed by Kuijpers-Jagtman, et 
al. [18], which is also similar to the scale used in a recent Americleft study [19]. The 
interrater reliability of the instrument is .80 which was attained at the calibration meeting for 
our multicenter study on Quality of Life in Children with Cleft. The EOD has been 
referenced in several publications [20, 21] and has demonstrated excellent discriminative 
validity. Using the EOD rating scale, the clinician rated standardized photographs of the 
infants. The caregivers used the same EOD scale to directly rate the appearance of their 
infants’ face.
Photographs
Standardized facial photographs were taken in four poses (frontal, right and left profile, and 
basal) pre-treatment and post-surgery (~13 months of age). An electronic manual was 
created to standardize photographs across sites. The full-face frontal photograph was taken 
at repose (not smiling) with the head oriented in a neutral position. Profile photographs were 
taken from both the left and right sides, again with the infant’s head in a neutral position. 
For basal photographs, infants were seated with their backs straight and their heads 
positioned at a 45-degree angle so that they were looking at the ceiling. Each photograph 
was cropped, blocked, and numerically coded by a research coordinator at each site and 
uploaded to a secure website. After cropping and blocking, a quality assurance review was 
carried out by the principal investigator at each site. A sample of the standardized poses is 
presented in Figure 1.
Thirty-seven sets of photographs of infants treated with NAM and 17 sets of infants treated 
without NAM were randomly selected for rating by an experienced cleft surgeon. A total of 
125 sets of photographs (54 Subjects x 2 time points + 17 randomly selected duplicate sets) 
were randomly ordered for rating. The clinician rater, blinded to treatment group, time point, 
and site, evaluated each set of photographs for each child at each of the two time points. 
This clinician was not responsible for providing any treatment to these infants. After 
viewing each photographic pose, the clinician rated the appearance of the infant’s face, nose, 
and lip using the EOD standard four-point scale.
Statistical Analysis/Modeling
Clinician and caregiver ratings were analyzed separately. The clinician rated each 
photographic pose (i.e., front, basal, left and right) of the infants (patients) separately (before 
and after treatment), whereas caregivers were asked to compare the overall appearance of 
their child’s nose, lips, and face to a child without a cleft in the general population. To 
compare the two ratings, we provide correlation coefficients. For the clinician’s rating of 
appearance, intra-rater reliability was assessed by weighted kappa for concordance. 
Bivariate comparisons report p-values derived from t-tests. Because data contain repeated 
measures of cleft severity, multilevel modeling was used to allow us to account for attrition 
and for regression to the mean. Laterality of cleft was associated with clinician-rated 
severity, so we accounted for whether clefts were right unilateral, left unilateral, or bilateral. 
We examined non-linearity in sensitivity analyses and examined distributional assumptions. 
Since clinician ratings were not normal, generalized linear modeling was used. We report 
results from the EOD comparing NAM-treated and NO-NAM treated children. Results from 
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all models provide beta-coefficients, standard errors, and exact p-values. To assess the 
explanatory power of each model, we calculated Pseudo-R2. Statistical analyses were done 
using Stata 13.1 IC [22].
RESULTS
Clinician Ratings
The concordance of the clinician ratings for the face, nose, and lips was excellent for the 
basal and frontal poses (Kappa > 0.83). The kappa values for the profile poses indicated 
good to excellent agreement (0.58 to 1.0). For the basal and frontal poses, 94% of the ratings 
for the face, nose, and lip were rated as severe before surgery. One-third to one-half of the 
infants in both treatment groups were rated as no different or only mildly different from 
normal post-surgery. Across the nose, lip, and face, the clinician rated infants as very 
different at baseline and mildly-moderately different post-surgery. The clinician was 
consistent across facial areas. The clinician found that overall, most photos indicated 
moderate to severe differences (Table 1) at baseline.
Examining clinician-rated appearance severity by treatment status (Table 2), we find that the 
NO-NAM group began with, on average, less severely rated clefts. The risk of more severe 
categorizations decreased between pre-treatment and post-surgery visits for NO-NAM 
patients. However, those with NAM treatment showed a decline in severity compared to 
those with traditional treatment. While this pattern was evident across lip, nose, and face, 
results were strongest when examining the nose (B=−0.52 (p=0.025), versus −0.37 on Table 
2). To visually clarify the pattern found in Table 3, we provide trajectories in clinician-rated 
appearance associated with treatment (Figure 2). Trajectories show that those treated with 
NAM therapy were, on average, more severely rated at baseline and then experienced larger 
declines in clinician-rated severity that were sufficient to eradicate pre-surgical differences 
in cleft-related severity.
Caregivers’ ratings
Caregivers rated the appearance difference of their children’s clefts as moderately different 
at baseline and mildly different post-surgery (Table 1). Caregiver ratings were moderately 
correlated with clinician ratings of frontal or basal, but not profile, views (ranging from 0.37 
to 0.55 overall). For example, the caregiver rating of the nose was associated with the 
clinician’s ratings of basal and frontal poses (r=0.55 and 0.44 respectively). Notably, there 
was no treatment group difference at baseline in caregiver ratings for the nose, lip, or face 
(P=0.492, 0.518, and 0.216 respectively).
Examining the association between NAM treatment and changes in caregiver-rated severity 
over time, NAM treatment was associated with improved caregiver ratings over the 
treatment period after surgery (Table 3, Model 1). Adjusting for caregiver age and sex 
(Model 2) and child’s cleft type (Model 3) did not change results. Subscale results suggested 
that the pattern of results was consistent for lip, nose, and face. However, the NAM 
treatment group showed larger benefits to the appearance of the nose: the NO-NAM group 
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showed no significant improvement in the nose over time (B=−0.19, P=0.299) while the 
NAM group showed a three-fold greater improvement over time (B=−0.58, P=0.007).
To visually explain these results, we provide trajectories of caregivers’ ratings of child’s 
appearance over child’s age in years by treatment status (Figure 3). Coefficients provided in 
Table 3 show that at post-surgery (at around 13 months of age), caregivers whose children 
underwent NAM reported seeing a greater improvement in their child’s overall appearance 
as compared to the caregivers of children who underwent traditional treatment.
DISCUSSION
This pilot project is the first non-randomized, prospective multicenter study comparing a 
cleft clinician’s and caregivers’ perceptions of infants’ appearance outcomes following 
primary cleft lip and nasal reconstruction with and without nasoalveolar molding (NAM). 
The blinded clinician/rater reported a more severe presurgical cleft difference in the NAM 
group compared to the NO-NAM group, and a greater improvement in facial appearance in 
the NAM group post-surgery. After surgical intervention, both the NAM and NO-NAM 
groups were found to have equivalent facial difference ratings, despite the greater pre-
treatment severity in facial difference in the NAM group. Longitudinal analyses of 
perception of change showed a statistically significant improvement in cleft lip and nasal 
repair for NAM caregivers compared to NO-NAM caregivers. NAM caregivers also rated 
their children as experiencing greater improvement in appearance differences over time than 
did their NO-NAM counterparts. The benefits of NAM were, in the caregivers’ ratings, 
strongest in relation to the appearance of the nose.
Examining caregiver perceptions of treatment outcomes is relevant and congruent with new 
initiatives in patient-oriented research and care [23]. While previous research has used 
professional ratings of treatment photographs [24], this study is novel because it includes the 
caregivers, who are important stakeholders in their infants’ cleft treatment. Knowledge 
gained from this report and other patient-oriented outcomes studies has implications for: 1) 
informing treatment decision-making for both cleft teams and caregivers; 2) determining 
cost effectiveness of early cleft treatment options; and 3) providing baseline information on 
long-term cost effectiveness. To date, this report is the first to indicate that both professional 
and caregiver subjective evaluations exhibited greater appearance improvement among the 
NAM-treated children in comparison to traditional treatment without NAM.
Although this report represents the strongest scientific evidence to date on the effectiveness 
of NAM, the study is not without limitations. Patients were assigned to treatment group 
largely by institutional protocol and patient preference, not by randomization. Such may 
account for pre-treatment differences in clinician-rated severity in the NAM group. 
Although the surgeons at each of the study sites are experienced cleft surgeons, variations 
may exist in individual surgical skills, techniques, and outcomes. While randomization is the 
best way to control for unobserved surgical experience [26], ethical and logistical difficulties 
often limit the utility of such methods. In our results, there is no definitive reason to believe 
that NAM treatment would unduly influence caregivers’ views of their own infants over 
time. Because the study is observing caregivers as they proceed through their agreed-upon 
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scheduled treatments, and not through an intervention provided by the study itself, it is 
unlikely that NAM and NO-NAM caregivers would be differently influenced by study 
participation. Furthermore, the clinician rater was blinded and photos were both duplicated 
and randomized, thereby removing the possibility of an association between treatment and 
the outcome. Moreover, the clinician and caregiver ratings were associated suggesting that 
both were similarly rating severity of the child’s cleft, and results from both find larger 
improvements in cleft severity associated with NAM treatment. Relying on one clinician 
provides useful clarity and reduces unnecessary variability in clinician ratings and the 
excellent intrarater reliability found in this study is noteworthy. However, results may be 
more or less severe because of the clinician’s specific characteristics. Future studies should 
use a panel of expert clinicians to provide more generalizable estimates of cleft severity. 
Finally, while the EOD is a four-point scale that has been used in multiple studies and has 
demonstrated positive psychometric worthiness [27, 28].
The fact that the results from this pilot study reference a small sample highlights the need 
for replication. Additionally, the treatment outcomes assessed are short-term, which 
underscores that follow-up and reassessing the effects of initial cleft treatment on facial 
growth and aesthetic form are crucial. Furthermore, the potential additional stress that NAM 
places on caregivers is just beginning to be understood and should be the focus of continued 
research [25]. Long-term follow-up in the NAM patient population should also address 
potential risks of this therapy to maxillary growth [10]. Finally, given that this study was 
underpowered to do so, future research should examine the bilateral cleft nasal deformity 
using long-term multicenter outcomes.
CONCLUSIONS
In this non-randomized, prospective multicenter study, the expert clinician rated the NAM 
group to have a more severe cleft pre-treatment. Caregivers reported significantly greater 
results in facial appearance after primary cleft lip and nasal repair in their infants who 
underwent NAM compared to caregivers whose infants underwent traditional care. 
Therefore, even if no significant differences were noted after primary lip and nasal surgery 
between the two treatment groups, the NAM patients had a greater level of improvement as 
they started with a more severe condition. Yet no group difference was observed in facial 
appearance post-surgery.
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Figure 1. 
Sample post-surgery photographs illustrating the four poses rated by the expert clinician.
Figure 1 A is frontal pose;
Figure 1 B is left pose;
Figure 1 C is right pose;
Figure 1 D is basal pose
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Figure 2. 
Treatment-related differences in clinician severity ratings of photographs by treatment type 
and pre/post-operative status among those who were NO-NAM treated (dark gray) and those 
who were NAM-treated (light gray box). 95% confidence intervals are provided (error bars).
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Figure 3. 
Expected longitudinal trajectories of change in caregivers’ ratings of children’s appearance 
as children age among those whose children are undergoing NO-NAM treatment (black 
dashed lines) and NAM treatment (solid black lines). 95% Confidence Intervals are provided 
(gray outlines).
Broder et al. Page 12
Plast Reconstr Surg. Author manuscript; available in PMC 2017 March 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Broder et al. Page 13
Ta
bl
e 
1
Ch
ar
ac
te
ris
tic
s o
f c
ar
eg
iv
er
 (n
=1
18
) a
nd
 cl
ini
cia
n (
n=
54
) r
ati
ng
s
C
ar
eg
iv
er
 ra
te
r
C
lin
ic
ia
n 
ra
te
r
M
ea
n
SD
M
ea
n
SD
Ca
re
gi
ve
r r
at
in
gs
Li
p
B
as
el
in
e
2.
03
0.
92
2.
65
0.
79
Po
st
-s
ur
ge
ry
1.
20
0.
76
1.
51
0.
62
N
os
e
B
as
el
in
e
1.
70
0.
91
2.
55
0.
88
Po
st
-s
ur
ge
ry
0.
97
0.
62
1.
40
0.
77
Fa
ce
B
as
el
in
e
1.
43
0.
89
2.
66
0.
79
Po
st
-s
ur
ge
ry
0.
74
0.
53
1.
62
0.
68
Ca
re
gi
ve
r a
ge
B
as
el
in
e
30
.2
9
6.
24
Pe
rc
en
t
Pe
rc
en
t
B
ila
te
ra
l c
le
ft
B
as
el
in
e
22
.4
1%
28
.3
0%
Ca
re
gi
ve
r m
al
e
B
as
el
in
e
9.
57
%
Cl
ef
t l
ip
/p
al
at
e
B
as
el
in
e
74
.1
4%
84
.5
4%
Plast Reconstr Surg. Author manuscript; available in PMC 2017 March 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Broder et al. Page 14
Table 2
Beta coefficients, standard errors, and exact p-values examining the association between treatment and 
clinician-rated cleft severity derived from random coefficients multilevel modeling adjusting for cleft type in 
relation to direction and area of photograph.
B SE P
NO NAM Treatment Reference
NAM Treatment 0.37 0.13 0.004
Post-surgical visit −1.11 0.11 <0.001
NO NAM Treatment Reference
NAM x Post-surgical visit −0.37 0.14 0.010
Constant 0.89 0.13
Pseudo-R2 0.29 <0.001
Note: Models account for pose, side of the face, cleft-type (right or left unilateral or bilateral).
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